The Wnt pathway controls cell fates, tissue homeostasis, and cancer. Its activation entails the association of b-catenin with nuclear TCF/LEF proteins and results in transcriptional activation of target genes. The mechanism by which nuclear b-catenin controls transcription is largely unknown. Here we genetically identify a novel Wnt/Wg pathway component that mediates the transcriptional outputs of b-catenin/Armadillo. We show that Drosophila Hyrax and its human ortholog, Parafibromin, components of the Polymerase-Associated Factor 1 (PAF1) complex, are required for nuclear transduction of the Wnt/Wg signal and bind directly to the C-terminal region of b-catenin/Armadillo. Moreover, we find that the transactivation potential of Parafibromin/Hyrax depends on the recruitment of Pygopus to b-catenin/Armadillo. Our results assign to the tumor suppressor Parafibromin an unexpected role in Wnt signaling and provide a molecular mechanism for Wnt target gene control, in which the nuclear Wnt signaling complex directly engages the PAF1 complex, thereby controlling transcriptional initiation and elongation by RNA Polymerase II.
INTRODUCTION
The development and homeostasis of multicellular organisms largely depends on cell-to-cell communication for the establishment and coordination of cell fates and the control of organ growth. Certain signaling molecules form concentration or activity gradients to provide cells in a tissue with positional information. Members of the Hedgehog and Wnt families of secreted signaling proteins, for example, induce subsets of target genes at defined distances from their source by activating conserved transduction cascades. Aberrant activation of these pathways can lead to various types of human cancer (Taipale and Beachy, 2001 ; reviewed by Gregorieff and Clevers, 2005) .
The canonical Wnt/Wingless (Wg) pathway controls transcription of target genes via its central component b-catenin (or its Drosophila homolog Armadillo, Arm), which serves as an interaction hub for a complex array of membrane-associated, cytosolic, and nuclear proteins (reviewed by Daniels et al., 2001) . At the cell membrane, b-catenin associates with a-catenin and E-cadherin in adherens junctions to provide a cell adhesion function. The remaining cytoplasmic b-catenin protein is constitutively marked for proteasomal degradation by Glycogen Synthase Kinase 3b (GSK-3b)-mediated phosphorylation (reviewed by Peifer and Polakis, 2000) . GSK-3b is part of a degradation complex also comprising Axin and APC, the product of the Adenomatous Polyposis Coli tumor suppressor gene. Upon binding of an extracellular Wnt ligand to members of the Frizzled (Fz) and LRP/Arrow receptors, Dishevelled (Dsh) is activated and assumed to disrupt the b-catenin degradation complex. As a result, the levels of free cytoplasmic b-catenin rise, and b-catenin enters the nucleus and interacts with TCF/LEF DNA binding proteins to initiate transcription of Wnt-responsive genes (reviewed by Nelson and Nusse, 2004) .
Key to understanding the evolution and function of b-catenin signaling and the consequences of aberrant b-catenin activity in cancer is the question of how a cell adhesion component, relocated to the nucleus, can promote and sustain transcription of genes. Although a number of interacting proteins have been identified, it is still poorly understood how they endow b-catenin with the ability to control the transcription of its targets. For example, the recent discovery and characterization of BCL9/ Legless (Lgs) and Pygopus (Pygo) indicated that Lgs links Pygo to b-catenin to form a core complex with TCF/LEF (Kramps et al., 2002; Hoffmans et al., 2005) , but how this complex uses Pygo to control the transcription of Wnt targets remains a mystery.
b-catenin consists of a central region containing 12 stacked Arm repeats flanked by structurally less well defined N-and C-terminal domains (NTD and CTD). The Arm repeat region mediates the binding to cadherins, Axin/ APC and TCF/LEF, allowing b-catenin to associate with adherens junctions, its destruction complex, or indirectly with DNA, respectively. Various lines of experimental evidence suggest that the two main outputs of b-catenin relating to its transcriptional activity emanate from its most N-terminally located Arm repeats as well as from its C-terminal region (Orsulic and Peifer, 1996; Hecht et al., 2000; Kramps et al., 2002) . The N-terminal activity can be attributed to the recruitment of Lgs and Pygo (Hoffmans et al., 2005; Stä deli and Basler, 2005) . In contrast, the transactivation activity imparted by the C-terminal part appears to be more complex since at least for Arm it has been found to stem from several subregions, of which the region closest to Arm repeat 12 plays the most important role for pathway output in vivo (Orsulic et al., 1996; Cox et al., 1999) . Proteins implicated in binding these C-terminal regions of b-catenin/ Arm include the histone acetyltransferases CBP and p300 and the ATP-dependent histone remodeling factor Brg1/ Brahma (Brm) (Hecht et al., 2000; Takemaru and Moon, 2000; Barker et al., 2001) , representing components of a general toolbox for chromatin remodeling (reviewed by Narlikar et al., 2002) . In addition to reorganized chromatin, transcriptional activation also depends on the recruitment and preparation of RNA Polymerase II (RNAPII) for the initiation and elongation of mRNA synthesis. However, for many signaling cascades, including the Wnt pathway, the mechanisms by which these later steps in transcriptional control are mediated remain poorly understood.
In this report, we describe the genetic identification and molecular characterization of Hyrax (Hyx), a novel component of the nuclear Wnt/Wg signaling pathway in Drosophila. Hyx is homologous to yeast Cdc73p, a component of the Polymerase-Associated Factor 1 (PAF1) complex, and is the Drosophila ortholog of human Parafibromin, the protein product of the Hyperparathyroidism-Jaw Tumor syndrome (HTP-JT) tumor suppressor gene HRPT2. Overexpression of Hyx is able to counteract compromised Lgs/Pygo activity. Conversely, reduction of Hyx function in vivo, as well as the knock-down of hyx or HRPT2 expression in cultured cells, abrogates Arm/b-catenin-mediated transduction of Wg and Wnt signals, respectively. These results reveal a novel and unanticipated role for Parafibromin as an important component of nuclear Wnt signaling. Moreover, we show that an N-terminal region of Parafibromin/Hyx directly interacts with the C-terminal region of bcatenin/Arm. Our results suggest a mechanistic model for Wnt/Wg target gene control in which the Pygo-mediated and the C-terminal outputs of b-catenin/Arm converge in the recruitment of the PAF1 complex, thereby activating transcriptional initiation and elongation by RNAPII.
RESULTS

Identification of hyx in a Genetic Screen for Wg Signaling Components
In a previous effort to isolate rate-limiting components of the Wnt/Wg signal transduction pathway, we carried out a screen for dosage-sensitive genes required for the manifestation of a gain-of-Wg-signaling phenotype in the Drosophila eye (Brunner et al., 1997; Kramps et al., 2002) . This screen uncovered mutations in the pangolin (pan), arm, lgs, and pygo genes, encoding the Drosophila homologs of TCF/LEF, b-catenin, BCL9, and Pygo, respectively, which together appear to form a tetrapartite DNA bound complex to control Wnt/Wg target genes (Belenkaya et al., 2002; Kramps et al., 2002; Parker et al., 2002; Thompson et al., 2002) . In an attempt to identify factors mediating the transcriptional output of this complex, we designed a complementary assay for genes that upon overexpression ameliorate a partial loss-of-Wg-signaling phenotype. A mutant form of Lgs (Lgs 17E ), which has weakened Arm binding capacity (Kramps et al., 2002) , was overexpressed in the wing pouch primordium, causing a notched wing margin phenotype by interfering in a dominant-negative manner with Arm-Lgs activity . We isolated two allelic EP-element insertions, P9 and P10, which effectively reverted the Lgs 17E phenotype ( Figure 1D and data not shown) when driven by Gal4 during larval development. However, ectopic gene expression driven by the P9 and P10 elements had no effect (1) on the viability or morphology of wild-type animals, (2) on phenotypes sensitized for the Dpp, Insulin, EGFR, and TNF/Eiger signaling pathways (see Experimental Procedures), nor (3) on the activity of the wing pouch enhancer used to drive Lgs 17E expression ( Figures   1H-1J ). The P9 and P10 elements inserted at cytological position 85C3 between two genes transcribed in opposite directions ( Figure 1G ): neuralized (neur), which encodes an E3 ubiquitin ligase involved in Notch signaling (Yeh et al., 2001) , and CG11990, a novel gene that we refer to as hyrax (hyx). Direct UAS-hyx transgenes based on a fulllength cDNA faithfully reproduced the reversion activity of the EP-elements ( Figure 1E ). Taken together, our results indicate that hyx encodes a normally non-rate-limiting product which upon overexpression is able to specifically overcome the dominant-negative action of Lgs 17E , raising the possibility that it functions as a novel, positive component in the Wg pathway.
hyx Is an Essential Gene Required for Wg Signal Transduction To gain more insight into hyx function, we sought to generate mutant hyx alleles. We used the fully penetrant reversion of the Lgs 17E phenotype by P9 activity as the basis for an EMS mutagenesis screen. Two revertant P9 chromosomes were recovered which failed to suppress the Lgs 17E phenotype ( Figure 1F and data not shown) and also failed to complement each other. Sequence analysis of the hyx locus of both chromosomes revealed premature stop codons in the hyx open reading frame (at R505 and Q461, respectively) ( Figure 1G ). We refer to these mutant hyx alleles as hyx 1 and hyx 2 . We subsequently identified a third, strongly hypomorphic hyx allele, caused by the EP-element insertion EY6898 into the hyx 5 0 UTR (hyx EY6898 ) ( Figure 1G ). Disruption of hyx function causes lethality during late embryogenesis (hyx 1 and hyx 2 ) or shortly after hatching (hyx EY6898 ) without obvious phenotypes. The early larval lethality of the hyx EY6898 allele could be substantially rescued to pharate adult stages by the presence of a ubiquitous Gal4 driver (rescuing hyx transcript formation from the exogenous promoter of the EP-element). Such animals exhibit severe leg defects with shortened and twisted segments ( Figures 1K and 1L ), reminiscent of phenotypes caused by hypomorphic pan and pygo alleles (Brunner et al., 1997; Parker et al., 2002; Thompson et al., 2002) as well as of the stubby legged habitus of the rock hyrax (Procavia capensis) (Hoeck, 1990) . We next generated clones of cells mutant for hyx by FLP-mediated mitotic recombination. Homozygous mutant clones in the adult female germ line did not develop into fertile oocytes. Hence maternal hyx products could not be removed to assess their role in patterning the embryonic epidermis. Similarly, somatic cell clones of the strong alleles hyx 1 and hyx 2 were rapidly eliminated from imaginal tissues. However, hyx EY6898 mutant cell clones induced 48 hr to 72 hr after egg laying grew readily in all imaginal discs although more slowly than their wild-type twinspots (data not shown). We thus continued our assays using hxy EY6898 with the potential caveat that it might uncover only particularly sensitive aspects of hyx function. hxy EY6898 clones in the wing imaginal disc showed a severe reduction or loss of expression of Distal-less (Dll), a target of the Wg pathway (Zecca et al., 1996; Neumann and Cohen, 1997) (Figures 2A-2C ). Failure to upregulate Dll expression could in principle be attributed to either a specific defect in Wg signal transduction or to a general (Phillips and Whittle, 1993) . We also noted patterning abnormalities that have no obvious relationship to Wg signaling, such as formation of ectopic vein material ( Figure 2P ) and deformed eye morphology (data not shown). Collectively, therefore, we conclude that hyx is an essential gene and that it is required autonomously in Wg receiving cells for the transduction of the Wg signal. But, unlike dedicated Wg signaling components, such as Lgs and Pygo, Hyx also plays a role in other developmental processes.
Hyx Functions Downstream of Axin and APC2
To validate and extend our examinations of the role of Hyx in the Wg pathway, we used a Drosophila S2 cell signaling assay based on a stably integrated Luciferase reporter construct containing multiple TCF/LEF binding sites (Schweizer and Varmus, 2003) . The pathway was activated by Wg secreted from cocultured cells (van Leeuwen et al., 1994) , resulting in potent induction of Luciferase expression ( Figure 3A ). Targeting transcripts of the negative regulators Axin and APC2 by RNAi also increased the Luciferase readout, even in the absence of the Wg ligand. Conversely, RNAi against sequences encoding the positively acting components (dsh, arm, lgs, and pygo) strongly reduced the transcriptional response to Wg ( Figure 3A and data not shown). Two different dsRNAs for hyx were prepared; both caused a severe reduction of Wg pathway activity ( Figure 3A ). Importantly, independent Luciferase reporters systems designed to monitor the response to other signals, e.g., Dpp or heavy metal ions, were not significantly affected by hyx RNAi (Figure 3B ). These results confirm our conclusion that hyx encodes a product required for Wg signaling output and provide an experimental basis for analyzing the epistatic relationship between Hyx and known components of the Wg pathway. We next employed combinatorial RNAi in our S2-cell reporter system. The transcriptional induction resulting from RNAi against Axin (data not shown) or APC2 was significantly reduced when dsRNA against lgs was included. An even stronger reduction was obtained by administering dsRNA against hyx ( Figure 3C ). We interpret these observations as an indication that Hyx, like Lgs, acts downstream of the Arm degradation complex in Wg transducing cells.
In order to extend these findings to endogenous Wg target genes, we used quantitative RT-PCR (qRT-PCR) to analyze the transcriptional behavior of D-frizzled 3 (Dfz3), naked cuticle (nkd), and CG5895, three genes presumed to be direct targets of the Arm/Pan complex (Sivasankaran et al., 2000; Zeng et al., 2000) (D. Soldini, C.M., and K.B., unpublished data). These genes were readily induced in S2 cells upon RNAi-mediated knock-down of Axin ( Figure 3D) ; the expression of all three genes, however, was reverted to normal levels upon coadministration of RNAi against either lgs or hyx ( Figure 3D ). Importantly, the transcription of the four Wg independent genes dRheb, TOR, brinker (brk), and dInr showed no significant transcriptional change in response to RNAi against either GFP, Axin, lgs, hyx, or combinations thereof ( Figure 3E ). Since hyx expression was only severely reduced but not abolished in our in vivo and in vitro experiments, we cannot rule out that pathways other than those governed by Wg also depend on Hyx function but are more resilient to reductions in its activity. In any case, our in vivo and tissue culture results clearly indicate that hyx encodes an important signaling component of the Wg pathway.
hyx Encodes the Drosophila Homolog of Human Parafibromin Interestingly, we found that eukaryotic genomes usually contain a single potential hyx homolog ( Figure 4A ). The presumptive Hyx protein sequence, however, did not reveal any functionally known domains with high confidence. Based on similarity to the predicted metazoan proteins, we subsequently identified three potential nuclear localization signals ( Figure 4B ). These observations suggest that Hyx represents a highly conserved and possibly nuclear protein of ancient eukaryotic origin.
The best characterized Hyx homolog is Cdc73p (Figures 4A and 4B), a nuclear factor of the Saccharomyces cerevisiae Polymerase-Associated Factor 1 (PAF1) complex. The PAF1 complex, comprising the factors Paf1p, Cdc73p, Rtf1p, Ctr9p, and Leo1p, binds to RNAPII via Cdc73p and Rtf1p and coordinates histone modifications associated with transcription (reviewed by Sims et al., 2004) . Significant sequence similarity between Hyx and Cdc73p is limited to the C-terminal part, starting approximately from amino acid 359 in Hyx ( Figure 4B ). Interestingly, Hyx shares with its metazoan homologs additional sequence similarities in the N-terminal domain, which are not present in yeast and plants, suggesting that these proteins have acquired metazoan-specific functions (see below).
The human homolog of Hyx has recently been discovered to be the product of the HRPT2 tumor suppressor gene involved in Hyperparathyroidism-Jaw Tumor syndrome (HPT-JT) (Carpten et al., 2002) . Based on some of this syndrome's characteristic features-parathyroid tumors and ossifying jaw fibromas-this product is referred to as Parafibromin (Carpten et al., 2002) . While the role of Parafibromin in parathyroid glands and other tissues is unknown at present, there is a tight correlation between melanogaster) that appears to be expressed exclusively in testis (Parisi et al., 2004) . The scale bar represents the evolutionary change per residue. Proteins are designated by their published name or GenBank accession number, and abbreviated species names are as follows (from top to bottom): H. sapiens, M. musculus, X. laevis, D. rerio; A. melifera, A. gambiae, D. melanogaster, D. pseudoobscura, D. melanogaster, C. elegans; D. discoideum, O. sativa, A. thaliana; S. cerevisiae, C. albicans, N. crassa, and S. pombe mutations in HRPT2 and familial, as well as sporadic, cases of this disease (reviewed by Wang et al., 2005) . Based on these findings and our previous experimental results, we hypothesized that Hyx-and by extension Parafibromin-represent nuclear factors of a metazoan PAF1 complex which mediate Wnt/Wg target gene activation upon recruitment by the nuclear b-catenin/Arm complex. In the subsequent experiments, we set out to verify and refine this model.
Parafibromin Can Functionally Substitute for Hyx
To address the functional relationship between Hyx and its human homolog, we generated a UAS-HRPT2 transgene containing the entire Parafibromin protein coding region. As shown in Figures 5A-5C , expression of this transgene fully reverted the Lgs 17E -mediated wing notching phenotype. Thus Parafibromin, like Hyx, has the capacity to enhance the output of a compromised Wg pathway upon overexpression.
We next established transgenic lines with a construct encoding N-terminally HA-tagged Parafibromin driven by the weak and ubiquitous tubulin-1a promoter (tub1a-HA-HRPT2). All transgene insertions analyzed fully rescued all mutant hyx allele combinations to adulthood without obvious phenotypic defects ( Figure 5D ). HA-Parafibromin was exclusively found in the nuclei of the transgene-expressing cells, independent of their Wg pathway activity ( Figures 5E-5J ) and consistent with a nuclear function of Parafibromin/Hyx (Hahn and Marsh, 2005; Rozenblatt-Rosen et al., 2005 ). An analogous construct encoding yeast Cdc73p (tub1a-HA-cdc73), however, did not show any significant rescue activity (data not shown). Hence Parafibromin, but not Cdc73p, can serve as a functional homolog of Hyx.
Together, these findings support our notion that Hyx is a nuclear component involved in Wg target gene activation and raise the intriguing possibility that Parafibromin and the Cdc73-related proteins in other metazoans have a similar function.
Wnt Signaling in HEK 293T Cells Is Sensitive To Parafibromin Levels
We next wanted to know if increased Parafibromin levels positively influence Wnt signaling in human cells. HEK 293T cells were transfected with varying amounts of a CMV-promoter driven HA-HRPT2 construct. Wnt pathway activity was monitored with the TOPFLASH assay (Korinek et al., 1997) upon induction by Lithium Chloride (LiCl), an inhibitor of GSK-3b (Jho et al., 2002) . Overexpression of Parafibromin caused a 2-to 3-fold increase in TOPFLASH activity ( Figure 5K ), suggesting that Parafibromin positively synergizes with components of the human Wnt signaling pathway to enhance the TCF/LEFdependent transcriptional output.
To decrease HRPT2 levels, we used two independent small interfering RNAs (siRNAs) against HRPT2. Both siRNAs knocked HRPT2 mRNA levels down to approximately 20% within 48 hr after transfection into HEK 293T cells without any obvious deleterious effects on cell viability or control-gene expression (data not shown). However, comparable to the effect of an siRNA against hPYGO2, knockdown of HRPT2 reduced the TOPFLASH readout ( Figure 5L ). Since neither of the two HRPT2 siRNAs matches the hyx mRNA sequence, we could introduce Hyx to this system, essentially replacing Parafibromin with its Drosophila homolog. When cotransfected with either of the HRPT2 siRNA, our HA-hyx construct was able to restore the TOPFLASH readout ( Figure 5L and data not shown). Interestingly, forms of Hyx that lack the N or the C terminus as well as full-length yeast Cdc73p failed to significantly reverse the RNAi effect ( Figure 5M ). Together, these results indicate that Parafibromin is required for Wnt signaling in human cells and that full-length Hyx can substitute for Parafibromin in this function. These findings further support the notion that Parafibromin and Hyx are bona fide orthologs and that metazoan Cdc73-related proteins share a conserved role in nuclear Wnt signaling.
Existence of a Stable Parafibromin/b-catenin Complex
The sequence homology to Cdc73p together with the results obtained so far suggest that Parafibromin/Hyx and, by extension, the PAF1 complex promote Wnt/Wg target gene expression. To test if there is a physical link between Parafibromin and the nuclear b-catenin complex, we incubated GST-DN-b-catenin or GST coupled to glutathione sepharose beads with lysates of HEK 293T cells expressing HA-Parafibromin. GST-DN-b-catenin beads, but not GST beads, efficiently retained HA-Parafibromin (Figure 6A) ; we could also precipitate a complex with HAParafibromin using GST-hTCF4 1-130 , a minimal hTCF4 fragment containing the b-catenin interaction domain (Figure 6B) . Importantly, using an anti-Parafibromin antibody, endogenous b-catenin could be coimmunoprecipitated along with endogenous Parafibromin from HEK 293T and HeLa cells as well as mouse embryonic fibroblasts ( Figures 6C and 6E and data not shown). Similarly, anti-HA pull-downs from S2 cells transiently expressing HAHyx coprecipitated endogenous Arm (data not shown). Endogenous b-catenin could also be coprecipitated by another component of the PAF1 complex, hLeo1 ( Figures  6D and 6E) , suggesting that the PAF1 complex as a whole can stably interact with b-catenin in vivo.
Parafibromin/Hyx Directly Binds b-catenin/Arm via a Confined Domain in Its Metazoan-Specific N Terminus
The interaction between Parafibromin and b-catenin described above could be either direct or indirect. Using the yeast-2-hybrid system, we detected a specific interaction between Parafibromin and b-catenin ( Figure 6F ), suggesting direct protein-protein binding. More definite support for this was obtained from in vitro experiments in which GST-Parafibromin and GST-Hyx efficiently pulled down in vitro translated full-length b-catenin and N-terminally truncated Arm, respectively ( Figure 6G and data not shown). In an analogous complementary set of pulldowns, GST-DN-b-catenin and GST-DN-Arm interacted with in vitro translated full-length Parafibromin and Hyx ( Figure 6H and data not shown). Taken together, the interaction studies strongly suggest that Parafibromin/Hyx and b-catenin/Arm coexist in a complex by virtue of a direct protein-protein interaction.
To identify the region of b-catenin necessary for Parafibromin binding, we performed a series of GST pull-down assays with different in vitro translated b-catenin fragments. The results indicate that repeat 12 together with the C-terminal domain (CTD) harbors a Parafibromin binding site ( Figure 6G ). We also found that Hyx interacts with the corresponding part of Arm in a similar set of experiments (data not shown), indicating that the interaction region is evolutionarily conserved. Our results also allow us to conclude that the C-terminally truncated protein products of several mutant arm alleles, for example, Arm , 349-538) as well as yeast Cdc73p cannot substantially rescue the effect of HRPT2 siRNA (M). The Hyx C-terminal fragment additionally contains a SV40 largeT antigen NLS to ensure proper nuclear translocation (Yart et al., 2005) . In (K-M), the relative Luciferase activity is normalized to that obtained with expression of CMV-EGFP or using siRNA against GFP, respectively.
We next mapped the b-catenin/Arm binding domain of Parafibromin/Hyx. A GST-fusion comprising the N terminus (amino acids 1-343) of Parafibromin interacted with b-catenin in vitro, while the C-terminal half of Parafibromin (amino acids 344-538), harboring the core Cdc73 homology region, failed to do so ( Figure 7A ). Further truncations allowed us to define a stretch of amino acids (200-250) essential for b-catenin binding ( Figure 7A ). This stretch corresponds to an evolutionarily conserved block in Parafibromin/Hyx proteins centered on amino acids 218-263, which itself turned out to be sufficient for potent b-catenin binding ( Figure 7A ). We therefore propose that amino acids 218-263 of Parafibromin constitute a discrete b-catenin interaction domain (CID) (Figures 4 and 7B) . In addition to the CID, our genetic analysis in vivo and the ClustalW alignments suggest that the Parafibromin/Hyx N terminus might contain further ''activator binding'' domains, potentially linking the PAF1 complex to other transcription-dependent signaling outputs.
Parafibromin Function in Wnt Signaling Depends on BCL9/Lgs and Pygo
Originally, we found that hyx overexpression could counteract the dominant-negative effect of Lgs
17E
, suggesting a functional crosstalk between Hyx and Lgs/Pygo. We thus asked whether the Parafibromin/Hyx-mediated output of b-catenin activity is dependent on BCL9/Lgs and Pygo. We made use of the Parafibromin activity assay described above, in which an increase in Parafibromin levels enhances the transcriptional activity of the TOPFLASH reporter upon pathway stimulation (see Figure 5K ). This enhancement of pathway activity was greatly reduced when hPYGO-2 was targeted by RNAi, indicating that pathway stimulation by increased levels of Parafibromin depends on Pygo ( Figure 7C ). To corroborate this conclusion and extend it to BCL9/Lgs, we used a mutant (F) Proposed mode of action for the nuclear Wnt/Wg signaling core complex. BCL9/Lgs recruits Pygo to TCF/LEF bound b-catenin at its N-terminal Arm repeats, exposing the Pygo NHD. Parafibromin/Hyx recruits the PAF1 complex and binds directly via its CID to the b-catenin/Arm C-terminal part, potentially after CBP/p300 and Brg-1/Brm have remodeled surrounding chromatin to enable RNAPII transactivation. Following mRNA transcription initiation, the PAF1 complex could be transferred together with Parafibromin/Hyx to RNAPII in order to control histone modifications associated with transcriptional elongation.
form of b-catenin that can no longer recruit BCL9/Lgs due to a single amino acid exchange in its BCL9/Lgs binding site (D164A) (Hoffmans and Basler, 2004) . While the activity of wild-type b-catenin tethered to DNA by a Gal4 DNA binding domain (G4DBD-b-catenin wt ) shows an enhanced UAS-Luciferase transcription when Parafibromin is overexpressed, the mutant form (G4DBD-b-catenin D164A ) is no longer responsive to increased levels of Parafibromin ( Figure 7D ). This apparent epistatic relationship between BCL9-Pygo and Parafibromin could be interpreted to indicate that Parafibromin/Hyx acts downstream of, or in parallel to, BCL9/Lgs-Pygo. Given that both factors are recruited to b-catenin, a parallel concomitant action is more likely.
In agreement with this notion, we found biochemical evidence that the Parafibromin/b-catenin complex also contains BCL9 and Pygo. Full-length HA-BCL9 or HA-hPygo2 as well as a C-terminally truncated version of hPygo2 lacking the BCL9-interacting PHD domain (HA-hPygo2 DPHD ) were expressed in HEK 293T cells and immunoprecipated with an anti-Parafibromin antibody. Western blot analysis revealed that Parafibromin and b-catenin coprecipitated with BCL9 and full-length hPygo2 but not with hPygo2 DPHD ( Figure 7E ). Together, our results indicate that the scaffold protein b-catenin assembles a nuclear Wnt signaling complex comprising BCL9/Lgs-Pygo as well as Parafibromin. They further suggest that the transcriptional output of b-catenin depends on the concomitant activities of Pygo and the PAF1 complex, providing an explanation for our original finding that overexpression of Hyx could compensate for the experimental reduction of Lgs function in vivo.
DISCUSSION
Wnt signaling proteins govern many important cellular events during development, tissue homeostasis, and tumorigenesis. In most cases, the effects of these signals are brought about by transcriptional changes of target genes. It is thought that Wnt targets are activated by b-catenin-mediated recruitment of auxiliary factors to TCF/ LEF DNA binding proteins. Despite the identification of both dedicated and more general factors influencing the transcriptional output of b-catenin activity, little is known about how these proteins act together to control Wnt target gene expression. Here we extend the current understanding of Wnt/Wg signaling by the genetic identification and molecular characterization of Hyrax (Hyx) and its human ortholog Parafibromin, a novel transcriptional mediator of b-catenin/Arm. Parafibromin/Hyx is homologous to Cdc73p, a component of the Saccharomyces cerevisiae PAF1 complex, which is an evolutionarily conserved RNA Polymerase II interacting complex involved in regulating transcriptional initiation and elongation. The results presented here suggest a model for Wnt/Wg target gene control in which the C-terminal region of b-catenin recruits Parafibromin/Hyx, thereby engaging the PAF1 complex for the transcriptional upregulation of target genes. complex (Rozenblatt-Rosen et al., 2005; Yart et al., 2005; Adelman et al., 2006) . The yeast PAF1 complex has originally been found associated with initiating and elongating forms of RNAPII (reviewed by Sims et al., 2004) . Moreover, the PAF1 complex interacts genetically and physically with the histone H2B ubiquitination complex, the Set1 methylase-containing COMPASS complex, and Set2, thus conferring control over a number of distinct histone modifications on RNAPII (reviewed by Hampsey and Reinberg, 2003; Krogan et al., 2003; Wood et al., 2003) . Together, these findings suggest important conserved functions of the PAF1 complex in coordinating histone modifications ''downstream'' of chromatin preparation on target promoters to ensure proper initiation, elongation, and memory of transcription (reviewed by Sims et al., 2004) . To date, Cdc73p has not been reported to interact directly or indirectly with a sequence-specific DNA binding transcription factor, and it is not clear how the PAF1 complex is recruited to its target genes. However, the metazoan homologs Parafibromin and Hyx share an extended N-terminal region, not present in Cdc73p, which we have found to physically interact with the core Wnt/Wg component b-catenin/Arm. It is thus tempting to speculate that during metazoan evolution, Cdc73 homology proteins evolved in their N-terminal sequences interaction domains for certain signal transduction pathways, such as the Wnt/ Wg pathway, while conserving C-terminal sequences for PAF1 complex and/or RNAPII association.
Hyx As a Novel Wg Pathway Component
Pygo As a Potential Coordination Module for Transcriptional Activators at the C Terminus of b-catenin/Arm b-catenin/Arm has two ''branches'' of transcriptional output, an N-terminal and a C-terminal branch, which can be separated experimentally . The N-terminal activity maps to Arm repeat 1 and can be attributed to the recruitment of Lgs and Pygo (Hoffmans et al., 2005; Stä deli and Basler, 2005) . Our results here suggest that Parafibromin/Hyx mediates an important aspect of the C-terminal output of b-catenin/Arm. The significance of any transcriptional activity mapping to C-terminal sequences of b-catenin/Arm is seemingly undermined by the finding that C-terminally truncated forms of Arm (such as the product of the allele arm XM19 ) are able to drive Wg target gene expression under certain experimental conditions (Cox et al., 1999; Tolwinski and Wieschaus, 2004) . However, the arm XM19 allele only exhibits robust signaling activity when its product is ''forced'' into the nucleus by overexpression of a membrane-tethered form of Arm and most likely uses the N-terminal Lgs/Pygo-dependent branch for this activity. Under physiological conditions, Arm XM19 is severely impaired for Wg signaling (Peifer et al., 1994; Cox et al., 1999) . Arm H8.6 , which only lacks a distal portion of the CTD, retains residual transactivation potential at 18ºC (Cox et al., 1999) . This apparent correlation between signaling activity and the extent of C-terminal integrity of Arm might reflect the capacity of Arm to recruit Hyx, a view consistent with our protein-protein interaction results. Recent advances in the understanding of how transcriptional activators modulate gene transcription suggest a sequential recruitment of histone acetylases (such as CBP/p300) and chromatin-remodeling complexes (like SWI/SNF) to target genes before RNAPII is contacted to initiate transcription on the prepared chromatin (reviewed by Narlikar et al., 2002; Roeder, 2005) . The b-catenin region encompassing Arm repeat 11 to the C terminus has previously been implicated in being necessary for chromatin remodeling using in vitro assays (Tutter et al., 2001 ).
Parafibromin/Hyx interacts with a region of b-catenin/Arm (repeat 12-C) ( Figure 6G ) that overlaps with the CBP/p300 binding site (repeat 10/11-C) and the Brg-1/Brm binding region (repeat 7-12) (Hecht et al., 2000; Takemaru and Moon, 2000; Barker et al., 2001 ). This raises the intriguing possibility of a concerted or sequential recruitment of chromatin remodeling factors during the control of Wnt/ Wg-responsive genes to the C-terminal portion of b-catenin/Arm, as is being reported for an increasing number of transcription factors (reviewed by Narlikar et al., 2002; Roeder, 2005) . In such a scenario, CBP/p300 and Brg-1/ Brm would, in sequential or arbitrary order, mediate chromatin remodeling steps at b-catenin/Arm-dependent target genes before the Parafibromin/Hyx-mediated recruitment of a PAF1-like complex orchestrates later transactivation steps involving the preparation of RNAPII with histone methylase complexes. In a final step, the PAF1 complex, including Parafibromin/Hyx, may be transferred from b-catenin/Arm to RNAPII to travel with it through the actively transcribed gene.
What role does the Wnt/Wg pathway component Pygo play in such a model? We found in several readouts that the Parafibromin/Hyx-enhanced transactivation activity of b-catenin is dependent on Pygo ( Figures 1A-1F, 7C , and 7D). We interpret the Pygo-Parafibromin/Hyx dependence as an indication for a more general cross talk between Pygo and proteins interacting with the C-terminal region of b-catenin/Arm ( Figure 7F ). Thus, Pygo could act as a flexible recruitment module to facilitate the exchange or stabilization of transactivating complexes that sequentially bind to the b-catenin C terminus. We therefore propose that Wnt/Wg target gene activation might be a concerted, Pygo-guided process, which dynamically coordinates the sequential action of transcriptional modulators at the central scaffold protein b-catenin/Arm.
Specificity
The yeast PAF1 complex shows cotranscriptional association with a wide range of genes and has therefore been considered a general transcription cofactor complex. However, deletion of individual components of this complex does not have a global effect on mRNA transcription but instead has a more selective impact on the transcription of only a subset of genes (Shi et al., 1997; Porter et al., 2002) . Currently, aside from our findings of an involvement in Wnt signaling, little is known about the target gene spectrum of metazoan PAF1-like complexes. Recently published data indicate that, as in yeast, the Drosophila PAF1-like complex is broadly associated with active genes but, functionally, Cdc73/Hyx seems only necessary for a subset of PAF1 complex targets (Adelman et al., 2006) . This would be consistent with a view that Parafibromin and Hyx provide an adaptor function only to certain transcription factors, such as, for example, b-catenin and Arm. Indeed, our in vivo and in vitro assays indicate that in contrast to a cohort of other genes, whose expression is constitutive or controlled by other pathways, Wg targets are remarkably sensitive to reduction of Hyx levels.
However, since our assays severely reduced but never abolished hyx expression, we can currently not evaluate the extent to which Hyx activity is also required for the transcription of targets of other pathways, which potentially are more resilient to reductions in Hyx levels.
Hyperparathyroidism, Parafibromin, and Wnt Signaling Originally, HRPT2 has been cloned as the tumor suppressor gene responsible for HPT-JT in both familial and sporadic cases (reviewed by Wang et al., 2005) . Little is known about the seemingly complex molecular pathology of parathyroid tumors and HPT-JT in particular (reviewed by Hendy, 2000) . Constitutive Wnt signaling is causally involved in many different tumor types. However, our findings clearly indicate a positive role for Parafibromin in the Wnt pathway; loss-of-heterozygosity of the HRPT2 tumor suppressor gene is thus expected to compromise rather than enhance pathway output. One way to reconcile this apparent discrepancy between a tumor suppressor function of HRPT2 and a positive sign of action of its product in Wnt signaling is to postulate that the transcriptional target(s) of Parafibromin relevant for HPT-JT encodes a negative growth regulator. It will be interesting to find out whether loss-of-function mutations in other positive Wnt pathway components might also cause hyperparathyroidism. It is also possible that the expression of the critical Parafibromin target(s) depends on another pathway that adopted the PAF1 complex for efficient target gene control. Clarification of these important issues will have to await the identification and analysis of the presumptive Parafibromin target(s) whose product(s) normally prevent parathyroid cancer.
EXPERIMENTAL PROCEDURES
Fly Stocks
For specificity assays, the following tester lines were used. Dpp: s168-Gal4, UAS-brk. Insulin pathway: GMR-Gal4, . TNF/Eiger: GMR-Gal4, UAS-egr. Other stocks used were Vectors and Constructs hyx constructs were PCR generated using the EST LD47989. HRPT2 constructs were based on the full-length EST V-1314 (Genecopoeia). Expression and IVT constructs were cloned into pcDNA3 (Invitrogen) and GST fusion constructs into pGEX-KG (Guan and Dixon, 1991) . Detailed descriptions of all constructs are available on request. The GenBank accession number for hyrax is DQ305403.
S2 Cell Culture and Quantitative Real-Time PCR RNAi in S2 cells was performed as described by Worby et al. (2001) . Cells were incubated for 24 hr to allow for turnover of the target protein before the Wg pathway was activated by coculture with Wg-producing cells (van Leeuwen et al., 1994) . Primer sequences used to generate specific dsRNAs can be obtained on request.
Total RNA was extracted from S2 cells using the Nucleospin RNA II kit (Macherey-Nagel). Quantitative PCR reactions were performed in triplicates and monitored using the Applied Biosystems SYBR Green kit and the ABI Prism 7900HT System (Applied Biosystems). All results were simultaneously normalized to the Actin5C, tubulin-1a, and TBP mRNA levels and calculated using the DDCt method (Applied Biosystems user bulletin #2, updated version 04/2001).
Mammalian Cell Culture Experiments
For TOPFLASH assays, HEK 293T cells were seeded at a density of 2-2.5 Â 10 5 cells/ml in DMEM, 10% FCS, 1% P/S and transfected 24 hr later with a total of 1.25 mg plasmid DNA per ml of medium by the Calcium Phosphate transfection method (0.5 mg pTOPFLASH, 0.25 mg CMV-RL, and 0.5 mg cargo or empty vector). In siRNA experiments, 3 mg siRNA per ml of medium was cotransfected. After 16-20 hr, the medium was replaced. Cells were stimulated by addition of LiCl or NaCl (control) at 25 mM final concentration 24 hr before harvesting. Cells were harvested 48 hr or 72 hr (siRNA experiments) after transfection, and Luciferase activities were measured by the Promega DualLuciferase reporter assay system. siRNAs (Qiagen) were: 
Protein Interaction Studies
The yeast-2-hybrid system and pull-down experiments were done as described in Kramps et al. (2002) . For immunoprecipitation experiments, HEK 293T cells were lysed in NP-40 lysis buffer (RozenblattRosen et al., 2005) . Antibodies used included mouse anti-FLAG (M2, Sigma); mouse HA-11 (BAbCO); rabbit a-HA (ICL); rabbit anti-Parafibromin and anti-hLeo1 (BL648, BL649, and BL677; Bethyl Labs) (Rozenblatt-Rosen et al., 2005) ; and mouse anti-b-catenin (clone 14, BD Biosciences).
